VRAY(Delisted)
Viewray·NASDAQ
--
--(--)
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About VRAY
Viewray, Inc.
A company that develops MRI-guided radiation therapy systems used for imaging and the treatment of cancer patients
1099 18th Street Suite 3000, Denver, CO 80202
--
Viewray, Inc., began operations as a Florida company in 2004 and was subsequently re-incorporated in Delaware in 2007. The company designs, manufactures and sells ViewRayMRIdian. MRIdian is an innovative system that integrates high-quality radiotherapy with concurrent magnetic resonance imaging (MRI). MRIdian combines MRI and external beam radiation therapy to simultaneously image and treat cancer patients. MRI is a widely used imaging tool that can clearly distinguish various soft tissues.
Company Financials
EPS
VRAY has released its 2023 Q1 earnings. EPS was reported at -0.16, versus the expected -0.16, meeting expectations. The chart below visualizes how VRAY has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
VRAY has released its 2023 Q1 earnings report, with revenue of 22.53M, reflecting a YoY change of 19.38%, and net profit of -28.86M, showing a YoY change of -11.97%. The Sankey diagram below clearly presents VRAY's revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
Related Symbols
You can ask Aime
No Data
